
Proceedings Paper
Incorporation of photosenzitizer hypericin into synthetic lipid-based nano-particles for drug delivery and large unilamellar vesicles with different content of cholesterolFormat | Member Price | Non-Member Price |
---|---|---|
$17.00 | $21.00 |
Paper Abstract
Low-density lipoproteins (LDL) and high-density lipoproteins (HDL) are attractive natural occurring vehicles for drug
delivery and targeting to cancer tissues. The capacity of both types of the lipoproteins to bind hydrophobic drugs and
their functionality as drug carriers have been examined in several studies and it has been also shown that mixing of
anticancer drugs with LDL or HDL before administration led to an increase of cytotoxic effects of the drugs in the
comparison when the drugs were administered alone. However, a difficult isolation of the lipoproteins in large quantity
from a biological organism as well as a variability of the composition and size of these molecules makes practical
application of LDL and HDL as drug delivery systems quite complicated. Synthetic LDL and HDL and large unilamellar
vesicles (LUV) are potentially suitable candidates to substitute the native lipoproteins for targeted and effective drug
delivery. In this work, we have studied process of an association of potent photosensitizer hypericin (Hyp) with synthetic
lipid-based nano-particles (sLNP) and large unilamellar vesicles (LUV) containing various amount of cholesterol.
Cholesterol is one of the main components of both LDL and HDL particles and its presence in biological membranes is
known to be a determining factor for membrane properties. It was found that the behavior of Hyp incorporation into
sLNP particles with diameter ca ~ 90 nm is qualitatively very similar to that of Hyp incorporation into LDL (diameter ca.
22 nm) and these particles are able to enter U-87 MG cells by endocytosis. The presence of cholesterol in LUV
influences the capacity of these vesicles to incorporate Hyp into their structure.
Paper Details
Date Published: 27 August 2014
PDF: 12 pages
Proc. SPIE 9166, Biosensing and Nanomedicine VII, 916604 (27 August 2014); doi: 10.1117/12.2060672
Published in SPIE Proceedings Vol. 9166:
Biosensing and Nanomedicine VII
Hooman Mohseni; Massoud H. Agahi; Manijeh Razeghi, Editor(s)
PDF: 12 pages
Proc. SPIE 9166, Biosensing and Nanomedicine VII, 916604 (27 August 2014); doi: 10.1117/12.2060672
Show Author Affiliations
Jaroslava Joniova, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Lab. Jean Perrin, CNRS, Univ. Pierre et Marie Curie (France)
Ludmila Blascakova, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Daniel Jancura, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Lab. Jean Perrin, CNRS, Univ. Pierre et Marie Curie (France)
Ludmila Blascakova, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Daniel Jancura, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Zuzana Nadova, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Franck Sureau, Lab. Jean Perrin, CNRS, Univ. Pierre et Marie Curie (France)
Pavol Miskovsky, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Franck Sureau, Lab. Jean Perrin, CNRS, Univ. Pierre et Marie Curie (France)
Pavol Miskovsky, Pavol Jozef Šafárik Univ. in Kolšice (Slovakia)
Published in SPIE Proceedings Vol. 9166:
Biosensing and Nanomedicine VII
Hooman Mohseni; Massoud H. Agahi; Manijeh Razeghi, Editor(s)
© SPIE. Terms of Use
